Market: NMS |
Currency: USD
Address: 445 Marine View Avenue
LENZ Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. The company is headquartered in Del Mar, California.
📈 LENZ Therapeutics, Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$41.14
-
Upside/Downside from Analyst Target:
101.29%
-
Broker Call:
14
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
25-50%
-
Net Income Growth Range (1Y):
<0%
-
Revenue Growth Range (1Y):
-
-
Upcoming Earnings Date:
-
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for LENZ Therapeutics, Inc.
| Date | Reported EPS |
|---|
| 2025-10-29 | - |
| 2025-07-30 | -0.53 |
| 2025-05-07 | -0.53 |
| 2025-03-19 | -0.46 |
| 2024-11-06 | -0.38 |
| 2024-08-14 | -0.4 |
| 2024-05-08 | -3.53 |
📰 Related News & Research
🔍 View more Reports
